Chromatographic analysis of antituberculosis drugs in biological samples.
Numerous chromatographic and non-chromatographic methods of analysis for anti-tuberculosis drugs and metabolites in biological tissues have been discussed in this review. Depending upon the analytical methodology selected, limits of detection range from microgram to picogram levels. A number of examples have been given of the correlation between different types of assay procedures. The metabolism and pharmacokinetics have been described along with some of the commonly associated problems of sample collection and storage.
M R
MR
Holdiness
D000636:Aminosalicylic Acids / Q000032:analysis; D000995:Antitubercular Agents / Q000032:analysis* / Q000378:metabolism; D002207:Capreomycin / Q000032:analysis; D002845:Chromatography; D003523:Cycloserine / Q000032:analysis; D004977:Ethambutol / Q000032:analysis; D005000:Ethionamide / Q000032:analysis; D006801:Humans; D007538:Isoniazid / Q000032:analysis; D007612:Kanamycin / Q000032:analysis; D007700:Kinetics; D008991:Monitoring, Physiologic; D011718:Pyrazinamide / Q000032:analysis; D012293:Rifampin / Q000032:analysis; D013307:Streptomycin / Q000032:analysis; D013828:Thioacetazone / Q000032:analysis; D014756:Viomycin / Q000032:analysis
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D002207:Capreomycin; D011718:Pyrazinamide; D007612:Kanamycin; D004977:Ethambutol; D003523:Cycloserine; D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin; D014756:Viomycin